Phase 4 Hearing Loss Trial, Recruiting NCT04192656 Sponsor: Beijing Tsinghua Chang Gung Hospital Condition: Hearing Loss
Back to Hearing Loss

Phase 4 Hearing Loss Trial, Recruiting

NCT04192656
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old
  • You have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) confirmed by a sleep study, with more than 15 breathing interruptions per hour
  • You have been diagnosed with sudden unexplained hearing loss, based on specific medical guidelines
  • Your sudden hearing loss started within the last week

Who may not be able to join:

  • Your sudden hearing loss has a known or identified cause
  • You have serious other health conditions alongside your hearing loss (confirm with trial site for which conditions apply)
  • You are pregnant or currently breastfeeding
  • Your sleep study shows 15 or fewer breathing interruptions per hour
  • Your hearing has already recovered by more than 50% by the time you would join the trial
  • You have previously been regularly treated with a PAP machine (a device that delivers air pressure to help you breathe during sleep)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Juanjuan Gao, MD, Beijing Tsinghua Changung Hospital

Phone: +86-13701396970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Beijing Tsinghua Chang Gung Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2019
Est. completion
1 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

hearing threshold

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov